Kymera Therapeutics, Inc.

KYMR · Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

Kymera Therapeutics, Inc. (KYMR), in the Healthcare sector, has 45 disclosed filings on Paydirt over the trailing twelve months from 12 corporate insiders: 1 purchase and 44 sales, 1 filed past the deadline. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 4 and filed Sep 4. The most active filer was Bruce Booth with 11 filings.

Add to watchlist

Filings, ttm

1 buy · 44 sells · 1 late

Traders, ttm

12 insiders

Volume, ttmiDollar value disclosed in the window

$645.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 4

Filed Sep 4

ADViAverage daily dollar volume

$102.3M

market data

Share price · 12M

$115 (+125.4%)

Adjusted for splits and dividends.

Volume by month

Buys $215.3M Sells $482.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Bruce Booth Director 11 filings NM

Nello Mainolfi Chief Executive Officer 9 filings JC

Jeremy G Chadwick Chief Operating Officer 6 filings PE

Pamela Esposito Director 5 filings JG

Jared Gollob Chief Medical Officer 5 filings NG

Noah Goodman Chief Business Officer 5 filings BJ

Bruce N. Jacobs Chief Financial Officer 4 filings ER

Elena Ridloff Director 4 filings

Recent filings

Brian AdamsSALE Chief Legal Officer $744K
6,371 sh across 3 lots
Exec Sep 4
Filed Sep 4 · 6:00 PM ET Nello MainolfiSALE Chief Executive Officer $6.0M
50,000 sh × $119.00
Exec Jul 7
Filed Jul 7 · 8:00 PM ET Bruce N. JacobsSALE Chief Financial Officer $8.9M
77,109 sh across 8 lots
Exec Jun 30
Filed Jul 2 · 6:30 PM ET Noah GoodmanSALE Chief Business Officer $387K
3,389 sh × $114.29
Exec Jul 1
Filed Jul 2 · 6:30 PM ET Nello MainolfiSALE Chief Executive Officer $9.2M
80,000 sh across 5 lots
Exec Jul 1
Filed Jul 2 · 6:30 PM ET Bruce BoothSALE Director $8.2M
75,750 sh across 12 lots
Exec Jun 29
Filed Jul 2 · 5:39 PM ET † Bruce BoothSALE Director $56.3M
511,764 sh across 27 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET Bruce BoothSALE Director $3.4M
31,126 sh across 7 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Biotechnology Value Fund Ii LpSALE Director $173.7M
1,630,658 sh across 4 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Noah GoodmanSALE Chief Business Officer $570K
5,000 sh across 2 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET Bruce BoothSALE Director $43.8M
396,626 sh across 22 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Bruce BoothSALE Director $34.5M
283,553 sh across 16 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET Noah GoodmanSALE Chief Business Officer $248K
2,500 sh × $99.00
Exec Jun 22
Filed Jun 22 · 5:30 PM ET Bruce BoothSALE Director $45.1M
476,201 sh across 26 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Bruce BoothSALE Director $3.3M
31,798 sh across 4 lots
Exec Jun 22
Filed Jun 22 · 5:30 PM ET Jeremy G ChadwickSALE Chief Operating Officer $1.3M
15,709 sh across 4 lots
Exec May 26
Filed May 27 · 5:30 PM ET Elena RidloffSALE Director $261K
3,000 sh × $87.00
Exec May 11
Filed May 11 · 5:30 PM ET Nello MainolfiSALE Chief Executive Officer $2.4M
29,064 sh across 2 lots
Exec Apr 29
Filed Apr 29 · 5:30 PM ET Bruce BoothSALE Director $531K
5,900 sh × $89.96
Exec Apr 22
Filed Apr 24 · 5:30 PM ET Bruce BoothSALE Director $820K
9,109 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET Jeremy G ChadwickSALE Chief Operating Officer $590K
6,551 sh across 2 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET Noah GoodmanSALE Chief Business Officer $121K
1,347 sh × $90.00
Exec Apr 14
Filed Apr 16 · 5:30 PM ET Noah GoodmanSALE Chief Business Officer $898K
10,264 sh across 4 lots
Exec Apr 9
Filed Apr 10 · 5:30 PM ET Jeremy G ChadwickSALE Chief Operating Officer $1.8M
21,140 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET Elena RidloffSALE Director $1.0M
12,000 sh across 3 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET